Abstract
Reverse genetics is a particularly powerful tool in non-model organisms with known whole-genome sequences enabling the characterization of gene and, thus, protein function via a mutant phenotype. Reverse genetic approaches require genetic manipulation techniques which often need to be specifically developed for non-model organisms; this can be fraught with difficulties. Here, we describe a genetic transformation protocol for the recently emerged human pathogen Candida auris to target the integration of DNA constructs into genomic locations via homology-directed repair using long flanking homologous sequences (>1 kb). We detail the generation of DNA constructs for gene deletion with dominant drug resistance markers via fusion PCR, the transformation of these constructs into chemically competent C. auris cells, and the confirmation of correct integration by PCR. This strategy can be adapted to deliver DNA constructs other than deletion cassettes, including promoter exchanges and protein tags.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rhodes J, Fisher MC (2019) Global epidemiology of emerging Candida auris. Curr Opin Microbiol 52:84–89. https://doi.org/10.1016/j.mib.2019.05.008
de Jong AW, Hagen F (2019) Attack, defend and persist: how the fungal pathogen Candida auris was able to emerge globally in healthcare environments. Mycopathologia 184:353–365. https://doi.org/10.1007/s11046-019-00351-w
Bravo Ruiz G, Lorenz A (2021) What do we know about the biology of the emerging fungal pathogen of humans Candida auris? Microbiol Res 242:126621. https://doi.org/10.1016/j.micres.2020.126621
Grahl N, Demers EG, Crocker AW, Hogan DA (2017) Use of RNA-Protein complexes for genome editing in non-albicans Candida species. mSphere 2:e00218–e00217. https://doi.org/10.1128/mSphere.00218-17
Day AM, McNiff MM, da Silva DA et al (2018) Hog1 regulates stress tolerance and virulence in the emerging fungal pathogen Candida auris. mSphere 3:e00506–e00518. https://doi.org/10.1128/mSphere.00506-18
Defosse TA, Courdavault V, Coste AT et al (2018) A standardized toolkit for genetic engineering of CTG clade yeasts. J Microbiol Methods 144:152–156. https://doi.org/10.1016/j.mimet.2017.11.015
Defosse TA, Le Govic Y, Vandeputte P et al (2018) A synthetic construct for genetic engineering of the emerging pathogenic yeast Candida auris. Plasmid 95:7–10. https://doi.org/10.1016/j.plasmid.2017.11.001
Kim SH, Iyer KR, Pardeshi L et al (2019) Genetic analysis of Candida auris implicates Hsp90 in morphogenesis and azole tolerance and Cdr1 in azole resistance. MBio 10:e02529–e02518. https://doi.org/10.1128/mBio.02529-18
Rybak JM, Doorley LA, Nishimoto AT et al (2019) Abrogation of triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris. Antimicrob Agents Chemother 63:e00057–e00019. https://doi.org/10.1128/AAC.00057-19
Rybak JM, Muñoz JF, Barker KS et al (2020) Mutations in TAC1B: a novel genetic determinant of clinical fluconazole resistance in Candida auris. MBio 11:e00365–e00320. https://doi.org/10.1128/mBio.00365-20
Bravo Ruiz G, Ross ZK, Gow NAR, Lorenz A (2020) Pseudohyphal growth of the emerging pathogen Candida auris is triggered by genotoxic stress through the S phase checkpoint. mSphere 5:e00151–e00120. https://doi.org/10.1128/msphere.00151-20
Mayr E-M, Ramírez-Zavala B, Krüger I, Morschhäuser J (2020) A zinc cluster transcription factor contributes to the intrinsic fluconazole resistance of Candida auris. mSphere 5:e00279–e00220. https://doi.org/10.1128/mSphere.00279-20
Shivarathri R, Jenull S, Stoiber A et al (2020) The two-component response regulator Ssk1 and the mitogen-activated protein kinase Hog1 control antifungal drug resistance and cell wall achitecture of Candida auris. mSphere 5:e00973–e00920. https://doi.org/10.1128/mSphere.00973-20
Baudin A, Ozier-Kalogeropoulos O, Denouel A et al (1993) A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae. Nucleic Acids Res 21:3329–3330. https://doi.org/10.1093/nar/21.14.3329
Wilson RB, Davis D, Mitchell AP (1999) Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol 181:1868–1874
Shevchuk NA, Bryksin AV, Nusinovich YA et al (2004) Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously. Nucleic Acids Res 32:e19. https://doi.org/10.1093/nar/gnh014
Shen J, Guo W, Köhler JR (2005) CaNAT1, a heterologous dominant selectable marker for transformation of Candida albicans and other pathogenic Candida species. Infect Immun 73:1239–1242. https://doi.org/10.1128/IAI.73.2.1239-1242.2005
Walther A, Wendland J (2003) An improved transformation protocol for the human fungal pathogen Candida albicans. Curr Genet 42:339–343. https://doi.org/10.1007/s00294-002-0349-0
Amberg DC, Strathern JN, Burke DJ (2005) Methods in yeast genetics: a cold Spring Harbor Laboratory Course Manual. Cold Spring Harbor Laboratory Press, New York
Acknowledgments
We are grateful for support from the Wellcome Trust [grant numbers 212524/Z/18/Z and 204815/Z/16/Z].
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Bravo Ruiz, G., Lorenz, A. (2022). Genetic Transformation of Candida auris via Homology-Directed Repair Using a Standard Lithium Acetate Protocol. In: Lorenz, A. (eds) Candida auris. Methods in Molecular Biology, vol 2517. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2417-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2417-3_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2416-6
Online ISBN: 978-1-0716-2417-3
eBook Packages: Springer Protocols